CH589596A5 - - Google Patents

Info

Publication number
CH589596A5
CH589596A5 CH1350973A CH1350973A CH589596A5 CH 589596 A5 CH589596 A5 CH 589596A5 CH 1350973 A CH1350973 A CH 1350973A CH 1350973 A CH1350973 A CH 1350973A CH 589596 A5 CH589596 A5 CH 589596A5
Authority
CH
Switzerland
Application number
CH1350973A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH589596A5 publication Critical patent/CH589596A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
CH1350973A 1972-09-20 1973-09-20 CH589596A5 (US20100175706A1-20100715-C00006.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00290590A US3850952A (en) 1972-09-20 1972-09-20 5-oxo-1beta-cyclopentane heptanoic acid derivative

Publications (1)

Publication Number Publication Date
CH589596A5 true CH589596A5 (US20100175706A1-20100715-C00006.png) 1977-07-15

Family

ID=23116685

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1350973A CH589596A5 (US20100175706A1-20100715-C00006.png) 1972-09-20 1973-09-20

Country Status (7)

Country Link
US (1) US3850952A (US20100175706A1-20100715-C00006.png)
JP (1) JPS4969637A (US20100175706A1-20100715-C00006.png)
CH (1) CH589596A5 (US20100175706A1-20100715-C00006.png)
DE (1) DE2347172A1 (US20100175706A1-20100715-C00006.png)
FR (1) FR2208898B1 (US20100175706A1-20100715-C00006.png)
GB (1) GB1426773A (US20100175706A1-20100715-C00006.png)
NL (1) NL7312215A (US20100175706A1-20100715-C00006.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965120A (en) * 1973-10-15 1976-06-22 Merck & Co., Inc. Prostaglandin E1 intermediate 3-carboxymethyl-4-methyl-2-1-carboxy-7-(loweralkoxy or aralkoxycarbonyl)-heptyl]-4-hydroxybutyric acid, γ-lactone, and processes of their preparation
DE2365101A1 (de) * 1973-12-21 1975-07-10 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
US4204999A (en) * 1976-02-20 1980-05-27 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for making bicyclic lactone derivatives for use as intermediates in the synthesis of prostaglandins
US4189596A (en) * 1976-05-24 1980-02-19 The Upjohn Company Preparing 2-arylalkanoic acid derivatives
US4169199A (en) * 1976-12-27 1979-09-25 Sagami Chemical Research Center Precursors for prostaglandin analogue and process for preparing the same
US8137617B2 (en) 2004-09-30 2012-03-20 Arkray, Inc. Thin film heater and analytical instrument
CN112358436B (zh) * 2020-11-19 2021-06-22 内蒙古源宏精细化工有限公司 一种1,2-环戊二甲酰亚胺的制备方法

Also Published As

Publication number Publication date
DE2347172A1 (de) 1974-03-28
GB1426773A (en) 1976-03-03
FR2208898A1 (US20100175706A1-20100715-C00006.png) 1974-06-28
JPS4969637A (US20100175706A1-20100715-C00006.png) 1974-07-05
NL7312215A (US20100175706A1-20100715-C00006.png) 1974-03-22
FR2208898B1 (US20100175706A1-20100715-C00006.png) 1978-03-24
US3850952A (en) 1974-11-26

Similar Documents

Publication Publication Date Title
FR2206549A1 (US20100175706A1-20100715-C00006.png)
FR2174177A1 (US20100175706A1-20100715-C00006.png)
AU473280B2 (US20100175706A1-20100715-C00006.png)
FR2208898B1 (US20100175706A1-20100715-C00006.png)
FR2179305A5 (US20100175706A1-20100715-C00006.png)
JPS4938304A (US20100175706A1-20100715-C00006.png)
FR2175035A1 (US20100175706A1-20100715-C00006.png)
JPS4960649A (US20100175706A1-20100715-C00006.png)
JPS49104184U (US20100175706A1-20100715-C00006.png)
JPS4924651A (US20100175706A1-20100715-C00006.png)
BR7310191D0 (US20100175706A1-20100715-C00006.png)
JPS4920510U (US20100175706A1-20100715-C00006.png)
JPS4921067U (US20100175706A1-20100715-C00006.png)
JPS4910294U (US20100175706A1-20100715-C00006.png)
JPS4877359A (US20100175706A1-20100715-C00006.png)
JPS49104650U (US20100175706A1-20100715-C00006.png)
CH575740A5 (US20100175706A1-20100715-C00006.png)
SE7204476L (US20100175706A1-20100715-C00006.png)
CH567780A5 (US20100175706A1-20100715-C00006.png)
CH577180A5 (US20100175706A1-20100715-C00006.png)
CH576183A5 (US20100175706A1-20100715-C00006.png)
CH575793A5 (US20100175706A1-20100715-C00006.png)
CH566815A5 (US20100175706A1-20100715-C00006.png)
CH574266A5 (US20100175706A1-20100715-C00006.png)
CH573507B5 (US20100175706A1-20100715-C00006.png)

Legal Events

Date Code Title Description
PL Patent ceased